Treatment length for children with tuberculosis now reduced: Research Medical Dialogues Bureau11 March 2022 12:02 PM ISTWashington: A recent UCL-led international trial that explored tuberculosis (TB) treatment effectiveness in children has led to a change in the World...
Darolutamide added to existing combination therapy in metastatic prostate cancer increases survival, NEJM says Medical Dialogues Editorial Team22 Feb 2022 9:00 AM ISTIn a new trial overall survival was remarkably longer with the combination of darolutamide, androgen-deprivation therapy, and docetaxel than with...
Cemiplimab significantly increases survival in recurrent cervical cancer: NEJM Medical Dialogues Editorial Team14 Feb 2022 9:30 AM ISTPatients with recurrent cervical cancer after first-line platinum-containing chemotherapy lived considerably longer with cemiplimab than with...
Endovascular Therapy Might Benefit Stroke Patients with Large Ischemic Region MD Bureau11 Feb 2022 9:00 AM ISTEndovascular therapy (ET) for acute ischemic stroke is now broadly recognized as one of the most powerful treatments. A recent study suggests that...
Secondary antibiotic prophylaxis reduces risk of rheumatic heart disease progression: Study Dr. Shravani Dali11 Feb 2022 9:00 AM ISTSecondary antibiotic prophylaxis reduces the risk of rheumatic heart disease progression, according to a new study published in the New England...
Mass Azithromycin Administration most effective for Yaws Eradication: NEJM Study Dr. Shravani Dali8 Jan 2022 9:15 AM ISTThree Rounds of Mass Azithromycin Administration are effective for Yaws Eradication, according to a recent study published in the New England ...
LentiGlobin effective for Sickle Cell Disease, finds NEJM Study Dr. Shravani Dali1 Jan 2022 9:00 AM ISTOne-time treatment with LentiGlobin is effective for Sickle Cell Disease, according to a recent study published in the New England Journal of...
Dolutegravir based therapy superior to standard care for children with HIV: NEJM Dr. Shravani Dali31 Dec 2021 9:00 AM ISTDolutegravir-based ART was superior to standard care for children and adolescents with HIV-1 infection, according to a recent study published in the...
IV Spesolimab rapidly effective in treatment of generalized pustular psoriasis: NEJM Dr. Shravani Dali24 Dec 2021 9:00 AM ISTSpesolimab is rapidly effective in the majority of patients within one week of its first intravenous infusion for patients suffering from generalized...
Pfizer vaccine Booster reduces Covid 19 infection and severity across all Age Groups: NEJM MD Editorial Team10 Dec 2021 11:43 PM ISTIn a new study conducted by Yinon M and team, it was found that across all age groups studied, participants who received a booster dose of the...
Combination of Rivaroxaban And Aspirin Improves CV Outcomes: COMPASS Trial Dr. Nandita Mohan4 Dec 2021 5:49 PM ISTCardiovascular diseases are the leading cause of death globally. Though new medications and the use of effective secondary prevention strategies, 5%...
Rivaroxaban and aspirin combo improves CV outcomes in stable ASCVD: COMPASS Trial MD Editorial Team4 Dec 2021 1:50 PM ISTCardiovascular diseases are the leading cause of death globally. Though new medications and the use of effective secondary prevention strategies, 5%...
